Equity
Cumulative Gross Losses and Impairments
JPMorgan Chase Cumulative Gross Losses and Impairments increased by 3.8% to $17.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.8%, from $22.92B to $17.71B. Over 5 years (FY 2020 to FY 2025), Cumulative Gross Losses and Impairments shows an upward trend with a 208.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2015
Last reportedQ1 2026May 1, 2026
Metric ID:
cumulative_gross_losses_and_impairmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.45B | $1.72B | $3.19B | $16.51B | $26.15B | $40.34B | $36.76B | $31.04B | $33.77B | $39.63B | $27.27B | $29.26B | $29.13B | $20.59B | $26.72B | $22.92B | $21.39B | $18.70B | $17.05B | $17.71B |
| QoQ Change | — | +18.5% | +85.4% | +417.6% | +58.4% | +54.2% | -8.9% | -15.6% | +8.8% | +17.4% | -31.2% | +7.3% | -0.4% | -29.3% | +29.8% | -14.2% | -6.7% | -12.6% | -8.8% | +3.8% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +88.0% | +29.1% | -1.8% | -25.8% | -5.7% | -13.7% | -48.0% | -2.0% | -21.7% | -26.6% | -9.2% | -36.2% | -22.8% |
Range$1.45B – $40.34B
CAGR+69.3%
Avg YoY Growth+306.4%
Median YoY Growth-7.5%
Cumulative Gross Losses and Impairments at Other Companies
Frequently Asked Questions
- What is JPMorgan Chase's cumulative gross losses and impairments?
- JPMorgan Chase (JPM) reported cumulative gross losses and impairments of $17.71B in Q1 2026.
- How has JPMorgan Chase's cumulative gross losses and impairments changed year-over-year?
- JPMorgan Chase's cumulative gross losses and impairments decreased by 22.8% year-over-year, from $22.92B to $17.71B.
- What is the long-term trend for JPMorgan Chase's cumulative gross losses and impairments?
- Over 5 years (2020 to 2025), JPMorgan Chase's cumulative gross losses and impairments has grown at a 208.5% compound annual growth rate (CAGR), from $61.00M to $17.05B.